Cargando…

Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins

Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be...

Descripción completa

Detalles Bibliográficos
Autor principal: Schöneich, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376966/
https://www.ncbi.nlm.nih.gov/pubmed/37509177
http://dx.doi.org/10.3390/biom13071142
_version_ 1785079399956086784
author Schöneich, Christian
author_facet Schöneich, Christian
author_sort Schöneich, Christian
collection PubMed
description Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be formulated based on information on impurities and stress factors resulting from manufacturing, transportation and storage. In more detail, this article focusses on autoxidation, metal-catalyzed oxidation, photo-degradation and radicals generated from cavitation as a result of mechanical stress. Emphasis is placed on probable rather than theoretically possible pathways.
format Online
Article
Text
id pubmed-10376966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103769662023-07-29 Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins Schöneich, Christian Biomolecules Review Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be formulated based on information on impurities and stress factors resulting from manufacturing, transportation and storage. In more detail, this article focusses on autoxidation, metal-catalyzed oxidation, photo-degradation and radicals generated from cavitation as a result of mechanical stress. Emphasis is placed on probable rather than theoretically possible pathways. MDPI 2023-07-17 /pmc/articles/PMC10376966/ /pubmed/37509177 http://dx.doi.org/10.3390/biom13071142 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Schöneich, Christian
Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title_full Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title_fullStr Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title_full_unstemmed Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title_short Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
title_sort primary processes of free radical formation in pharmaceutical formulations of therapeutic proteins
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376966/
https://www.ncbi.nlm.nih.gov/pubmed/37509177
http://dx.doi.org/10.3390/biom13071142
work_keys_str_mv AT schoneichchristian primaryprocessesoffreeradicalformationinpharmaceuticalformulationsoftherapeuticproteins